$OBLN ReShape Lifesciences Inc. Insider Trading Week 34/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ReShape Lifesciences Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ReShape Lifesciences Inc. in week 34/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Wood Todd Michael | Vice President of S ... | Grant | A | 1.82 | 5,494 | 9,999 | 5,494 | 0 to 5.5 K |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | HOWE LESLEY H | Grant | A | 1.82 | 27,472 | 49,999 | 53,334 | 25.9 K to 53.3 K (+106.23 %) | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Grant | A | 1.82 | 27,472 | 49,999 | 27,472 | 0 to 27.5 K | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Huang Kelly | Pres & Chief Operat ... | Grant | A | 1.82 | 54,945 | 100,000 | 119,945 | 65 K to 119.9 K (+84.53 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Grant | A | 1.82 | 107,142 | 194,998 | 338,634 | 231.5 K to 338.6 K (+46.28 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Hussainy Nooshin | VP of Finance | Grant | A | 1.82 | 32,967 | 60,000 | 113,387 | 80.4 K to 113.4 K (+40.99 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Young Donald R | VP of Quality Assur ... | Grant | A | 1.82 | 2,747 | 5,000 | 24,992 | 22.2 K to 25 K (+12.35 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Grant | A | 1.82 | 10,989 | 20,000 | 92,639 | 81.7 K to 92.6 K (+13.46 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 1.82 | 13,736 | 25,000 | 61,267 | 47.5 K to 61.3 K (+28.90 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | CEO | Grant | A | 1.82 | 109,890 | 200,000 | 566,948 | 457.1 K to 566.9 K (+24.04 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Wood Todd Michael | Vice President of S ... | Grant | A | 1.82 | 5,494 | 9,999 | 5,494 | 0 to 5.5 K |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Plovanic William J. | Chief Financial Off ... | Grant | A | 1.82 | 27,472 | 49,999 | 293,044 | 265.6 K to 293 K (+10.34 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | HOWE LESLEY H | Grant | A | 1.82 | 27,472 | 49,999 | 53,334 | 25.9 K to 53.3 K (+106.23 %) | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | DITTAMORE RAYMOND V | Grant | A | 1.82 | 27,472 | 49,999 | 27,472 | 0 to 27.5 K | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Stevenson Sharon | Grant | A | 1.82 | 27,472 | 49,999 | 27,472 | 0 to 27.5 K | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | MOATAZEDI DAVID | Grant | A | 1.82 | 5,494 | 9,999 | 5,494 | 11 K to 5.5 K (-50.00 %) | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Huang Kelly | Pres & Chief Operat ... | Grant | A | 1.82 | 54,945 | 100,000 | 119,945 | 65 K to 119.9 K (+84.53 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | MONDORE ROBERT H JR | VP of Operations | Grant | A | 1.82 | 13,736 | 25,000 | 13,736 | 0 to 13.7 K |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Brister Mark | Chief Technology Of ... | Grant | A | 1.82 | 107,142 | 194,998 | 338,634 | 231.5 K to 338.6 K (+46.28 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Hussainy Nooshin | VP of Finance | Grant | A | 1.82 | 32,967 | 60,000 | 113,387 | 80.4 K to 113.4 K (+40.99 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Young Donald R | VP of Quality Assur ... | Grant | A | 1.82 | 2,747 | 5,000 | 24,992 | 22.2 K to 25 K (+12.35 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | VandenBerg Amy | VP of Reg. and Clin ... | Grant | A | 1.82 | 10,989 | 20,000 | 92,639 | 81.7 K to 92.6 K (+13.46 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Drake Neil | VP Research and Dev ... | Grant | A | 1.82 | 13,736 | 25,000 | 61,267 | 47.5 K to 61.3 K (+28.90 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Rasdal Andrew P | CEO | Grant | A | 1.82 | 109,890 | 200,000 | 566,948 | 457.1 K to 566.9 K (+24.04 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Plovanic William J. | Chief Financial Off ... | Grant | A | 1.82 | 27,472 | 49,999 | 293,044 | 265.6 K to 293 K (+10.34 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | DITTAMORE RAYMOND V | Grant | A | 1.82 | 27,472 | 49,999 | 27,472 | 0 to 27.5 K | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | MOATAZEDI DAVID | Grant | A | 1.82 | 5,494 | 9,999 | 5,494 | 11 K to 5.5 K (-50.00 %) | |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | MONDORE ROBERT H JR | VP of Operations | Grant | A | 1.82 | 13,736 | 25,000 | 13,736 | 0 to 13.7 K |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | Kamdar Kim P. | Director | Buy | P | 1.82 | 54,945 | 100,000 | 68,345 | 13.4 K to 68.3 K (+410.04 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 1.82 | 1,648,359 | 3,000,013 | 5,634,329 | 4 M to 5.6 M (+41.35 %) |
| Aug 27 2018 | OBLN | OBALON THERAPEUTIC ... | INTERWEST PARTNERS X LP | 10% Owner | Buy | P | 1.82 | 1,098,901 | 2,000,000 | 3,552,239 | 2.5 M to 3.6 M (+44.79 %) |